Literature DB >> 18612046

Anti-inflammatory and anti-apoptotic effects of fumonisin B1, an inhibitor of ceramide synthase, in a rodent model of splanchnic ischemia and reperfusion injury.

Salvatore Cuzzocrea1, Rosanna Di Paola, Tiziana Genovese, Emanuela Mazzon, Emanuela Esposito, Concetta Crisafulli, Placido Bramanti, Daniela Salvemini.   

Abstract

Ceramide is a sphingolipid with potent proinflammatory and proapoptotic properties. This study sought to determine whether pharmacological inhibition of ceramide biosynthesis in the intestine attenuates pathophysiological sequelae of shock induced by splanchnic artery occlusion and reperfusion. Ischemia and reperfusion injury was induced in anesthetized rats by clamping both the superior mesenteric artery and the celiac artery for 45 min followed by reperfusion. Within 6 min after reperfusion, animals developed significant systemic hypotension with 100% of the animals dying during the 4-h period of reperfusion. In parallel experiments, animals were necropsied after 60 min of reperfusion, and the ileum was harvested for histological examination and assessment of biochemical changes. Administration of fumonisin B1 (FB1), a competitive and reversible inhibitor of ceramide synthase (3 mg/kg, 15 min before reperfusion), significantly reduced i) the increased ceramide expression as detected by immunohistochemistry; ii) peroxynitrite-mediated protein nitration; iii) infiltration of the reperfused intestine with polymorphonuclear neutrophils following a decrease in intercellular adhesion molecule-1 expression; iv) production of the proinflammatory cytokine tumor necrosis factor-alpha; and v) apoptosis in the ileum. Overall, tissue-protective effects were clearly observed upon histological examination of the ileum. These beneficial events were ultimately linked to decreases in both the development of hypotension and overall mortality. These results implicate ceramide as a key signaling molecule in splanchnic arterial ischemia and reperfusion-induced shock. The broader implications of our results provide a pharmacological rationale for the development of inhibitors of ceramide biosynthesis as novel therapeutics for ischemia and reperfusion-induced shock of several etiologies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18612046     DOI: 10.1124/jpet.108.139808

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  11 in total

1.  Dihydroceramide-based response to hypoxia.

Authors:  Cecilia M Devlin; Tim Lahm; Walter C Hubbard; Mary Van Demark; Kevin C Wang; Xue Wu; Alicja Bielawska; Lina M Obeid; Mircea Ivan; Irina Petrache
Journal:  J Biol Chem       Date:  2011-09-13       Impact factor: 5.157

Review 2.  Sphingolipids in neutrophil function and inflammatory responses: Mechanisms and implications for intestinal immunity and inflammation in ulcerative colitis.

Authors:  Mel Pilar Espaillat; Richard R Kew; Lina M Obeid
Journal:  Adv Biol Regul       Date:  2016-11-14

3.  Ceramide synthases 2, 5, and 6 confer distinct roles in radiation-induced apoptosis in HeLa cells.

Authors:  Judith Mesicek; Hyunmi Lee; Taya Feldman; Xuejun Jiang; Anastasia Skobeleva; Evgeny V Berdyshev; Adriana Haimovitz-Friedman; Zvi Fuks; Richard Kolesnick
Journal:  Cell Signal       Date:  2010-04-18       Impact factor: 4.315

4.  Ceramide synthase-dependent ceramide generation and programmed cell death: involvement of salvage pathway in regulating postmitochondrial events.

Authors:  Thomas D Mullen; Russell W Jenkins; Christopher J Clarke; Jacek Bielawski; Yusuf A Hannun; Lina M Obeid
Journal:  J Biol Chem       Date:  2011-03-09       Impact factor: 5.157

5.  Regulation of ceramide synthase-mediated crypt epithelium apoptosis by DNA damage repair enzymes.

Authors:  Jimmy A Rotolo; Judith Mesicek; Jerzy Maj; Jean-Philip Truman; Adriana Haimovitz-Friedman; Richard Kolesnick; Zvi Fuks
Journal:  Cancer Res       Date:  2010-01-19       Impact factor: 12.701

Review 6.  The consequences of genetic and pharmacologic reduction in sphingolipid synthesis.

Authors:  Raphael Schiffmann
Journal:  J Inherit Metab Dis       Date:  2014-08-28       Impact factor: 4.982

Review 7.  Dietary and Endogenous Sphingolipid Metabolism in Chronic Inflammation.

Authors:  Gregory H Norris; Christopher N Blesso
Journal:  Nutrients       Date:  2017-10-28       Impact factor: 5.717

8.  Administration of glucosylceramide ameliorated the memory impairment in aged mice.

Authors:  Yeonju Lee; Sergiy Oliynyk; Jae-Chul Jung; Jeong Jun Han; Seikwan Oh
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-04       Impact factor: 2.629

9.  Targeting the S1P/S1PR1 axis mitigates cancer-induced bone pain and neuroinflammation.

Authors:  Shaness A Grenald; Timothy M Doyle; Hong Zhang; Lauren M Slosky; Zhoumou Chen; Tally M Largent-Milnes; Sarah Spiegel; Todd W Vanderah; Daniela Salvemini
Journal:  Pain       Date:  2017-09       Impact factor: 7.926

Review 10.  Ceramide and Ischemia/Reperfusion Injury.

Authors:  Xingxuan He; Edward H Schuchman
Journal:  J Lipids       Date:  2018-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.